COVID-19 shatters decades of global health progress, slashing life expectancy

FHS
April 8, 2024
3:32 am

Study in The Lancet reveals COVID-19 as the second leading cause of death in 2021, disrupting three decades of progress in global health and reducing life expectancy by 2.2 years from 2019 to 2021 despite previous gains.

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays.

September 6, 2023

Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

Waters Corporation announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA Instruments

July 24, 2024

Genmab AS Patent Filing for Diffuse Large B-Cell Lymphoma Treatment

Share this article According to GlobalData’s company profile on Genmab, Personalized cancer vaccines was a key innovation area identified from patents. Genmab‘s grant share as

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.